Experiments in clinical samples have shown association between dysregulation of HAND2-AS1 and a number of tumor characteristics such as level of differentiation, tumor size, lymph node metastasis, and most importantly overall survival of patients. Here, HAND2 is linked to metastatic malignant neoplasm in the lymph nodes.